N-acetylcarnosine (NAC) drops for age-related cataract.

CONCLUSIONS: There is currently no convincing evidence that NAC reverses cataract, nor prevents progression of cataract (defined as a change in cataract appearance either for the better or for the worse). Future studies should be randomized, double-masked, placebo-controlled trials with standardised quality of life outcomes and validated outcome measures in terms of visual acuity, contrast sensitivity and glare, and large enough to detect adverse effects. PMID: 28245346 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28245346?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - February 27, 2017 Category: Journals (General) Authors: Dubois VD, Bastawrous A Tags: Cochrane Database Syst Rev Source Type: research